In this episode, Dr. Slavin joined by Shelly Cummings, MS, CGC Director of Myriad Oncology Medical Affairs, speak with Jennifer Klemp - PhD, MPH, MA Associate Professor of Medicine in the Division of Clinical Oncology at the University of Kansas Cancer Center about her experience with telegenetics and the effect that she has seen from the COVID-19 pandemic.
About Our Guest:
Jennifer Klemp, PhD, MPH, MA Associate Professor of Medicine in the Division of Clinical Oncology and Director of Cancer Survivorship, Co-Program Leader for Cancer Prevention and Control at the University of Kansas Cancer Center. She is the founder and CEO of Cancer Survivorship Training, Inc., an eLearning company supporting healthcare professionals, and is Principal of Cancer Resource Partners, LLC.